Grants and Contributions:

Back to search

Title:

Advancement of silver-oxygen scaffold gel production for anti-infective wound care

Agreement Number:

974259

Agreement Value:

$194,000.00

Agreement Date:

Jul 1, 2021 - Jul 31, 2022

Description:

Recent global events have shed light on the vulnerabilities within our health care systems. The growing threat of antimicrobial resistance is hailed as a pandemic in the making. As the antibiotics drug development pipeline dwindles, effective solutions to combat antimicrobial resistant strains of pathogenic bacteria are urgently needed. ETI has successfully developed a silver-oxygen scaffold gel device for the effective eradication of biofilm and pathogenic bacterium, including resistant clinical isolates, while facilitating wound healing. Employing a multidisciplinary team, this project will facilitate large scale production and distribution of this disruptive device to capture market share and combat resistance.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Edmonton, Alberta, CA T5J 4P6

Reference Number:

172-2021-2022-Q1-974259

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

861842136

Recipient Type:

For-profit organization

Recipient's Legal Name:

Exciton Technologies Inc.

Federal Riding Name:

Edmonton Centre

Federal Riding Number:

48014

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

339110